/ /

  • linkedin
  • Increase Font
  • Sharebar

    How will ophthalmology evolve in 2016?

    Ophthalmology Times Editorial Advisory Board members share their thoughts



    What advances are you anticipating in the coming year?

    Dr. McDonnell: “The first corneal inlay was recently approved as a therapy for presbyopia, and it will be interesting to see how that fares in the marketplace (see photo above, KAMRA inlay [AcuFocus, Inc.] next to contact lens).  Also, my counterparts outside the United States have had very positive results with corneal crosslinking, and it would be wonderful, in my opinion, to see this technology get approved for use here.”

    Dr. Olson: “New dry eye products.”

    Read more about the KAMRA inlay compared to lens-based options

    Jolie Higazi
    Jolie is the Content Specialist for Ophthalmology Times. She can be reached at [email protected]

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results